ANALYSIS: Four deaths in ten years: What Health Canada Was Hiding About Plasma Donation in Canada

ANALYSIS: Four deaths in ten years: What Health Canada Was Hiding About Plasma Donation in Canada
Credit: Adobe Stock

Deaths in Manitoba and Quebec

According to information obtained by Radio-Canada, the four deaths occurred between 2014 and 2024 in two provinces: Manitoba and Quebec. The available details remain fragmentary. Health Canada has confirmed the existence of these cases but has not released the full investigation reports, citing medical confidentiality and privacy protections. This veil of secrecy—however legally legitimate it may be—leaves the exact circumstances of each death, the protocols in place at the time, and, above all, the potential lapses that could have been avoided in the dark.

What we do know is that plasma donation is not a trivial matter. The plasmapheresis procedure—which involves drawing blood, separating the plasma by centrifugation, and then re-injecting the red blood cells into the donor’s arm—takes between 45 minutes and two hours. It is generally considered safe, but it carries real risks: allergic reactions, drops in blood pressure, air embolisms, and cardiovascular complications. These risks are rare, but they do exist. And when a donor dies at a collection center, the chain of responsibility—between the center’s operator, the national regulatory agency, and the ministry—must be examined without leniency.

The Lack of Transparency in Investigation Reports

What is striking about the revelation of these deaths is not so much the number itself as the difficulty in obtaining information. Health Canada has confirmed four deaths but has not initiated any proactive public communication. There was no press conference. No summary report is available to the public. No publicly announced update to the regulatory framework directly related to these events. The families of the deceased donors find themselves facing an institution that acknowledges the facts but fails to shed light on them.

This lack of transparency is not trivial in a sector where public trust is the lifeblood. Plasma donation relies entirely on citizens’ willingness to visit a center, undergo testing, and devote their time and bodies to a system that promises them safety and a sense of purpose. If that trust erodes—because the public learns through the media that people have died and that the authorities have not spoken about it—the entire supply of plasma-derived products could suffer. Opacity is therefore not just an ethical problem. It is a systemic risk.

A system that hides its accidents does not prevent them. It repeats them.

Share this post

facebook icon twitter icon linkedin icon
Copied!